News Focus
News Focus
Followers 0
Posts 7389
Boards Moderated 0
Alias Born 08/03/2012

Re: God_Father post# 26802

Thursday, 10/01/2020 10:19:53 PM

Thursday, October 01, 2020 10:19:53 PM

Post# of 202230
And we are still sub pennies after this bombshell. Wtf mate


BioClonetics is in the final stage of development of a parent monoclonal antibody ("mAb") (designated as Clone 3), which is non-toxic and has shown in initial in vitro testing to be effective against more than 95% of all strains and viral subtypes of HIV-1 against which it has been tested.

The proposed merger anticipated in the non-binding LOI will result in Charles Cotropia being appointed as CEO of the merged entity and Harry Zhabilov and Joseph Cotropia, MD, being appointed as co-CSO. Gaurav Chandra, MD, will serve as COO of the merged entity. Additional details will be disclosed as the transaction progresses.